[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Biopharmaceutical Buffers Market, Global Outlook and Forecast 2022-2028

April 2022 | 79 pages | ID: B84FE27B7624EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources.

This report contains market size and forecasts of Biopharmaceutical Buffers in global, including the following market information:

Global Biopharmaceutical Buffers Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Biopharmaceutical Buffers Market Sales, 2017-2022, 2023-2028, (K MT)

Global top five Biopharmaceutical Buffers companies in 2021 (%)

The global Biopharmaceutical Buffers market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Sterile Buffer Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Biopharmaceutical Buffers include GE Healthcare, Thermo Fisher Scientific, Danaher Corporation, Sartorius StedimBiotech, Merck, Eppendorf, Roche, Nova Biomedicals and Lonza, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biopharmaceutical Buffers manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Biopharmaceutical Buffers Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Biopharmaceutical Buffers Market Segment Percentages, by Type, 2021 (%)
  • Sterile Buffer
  • Non-sterile Buffer
Global Biopharmaceutical Buffers Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Biopharmaceutical Buffers Market Segment Percentages, by Application, 2021 (%)
  • Recombinant Proteins
  • Monoclonal Antibodies
  • Antibiotics
  • Probiotics
  • Other
Global Biopharmaceutical Buffers Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Biopharmaceutical Buffers Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Biopharmaceutical Buffers revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Biopharmaceutical Buffers revenues share in global market, 2021 (%)

Key companies Biopharmaceutical Buffers sales in global market, 2017-2022 (Estimated), (K MT)

Key companies Biopharmaceutical Buffers sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • GE Healthcare
  • Thermo Fisher Scientific
  • Danaher Corporation
  • Sartorius StedimBiotech
  • Merck
  • Eppendorf
  • Roche
  • Nova Biomedicals
  • Lonza
  • Becton, and Dickinson and Company
  • GEA
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Biopharmaceutical Buffers Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Biopharmaceutical Buffers Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BIOPHARMACEUTICAL BUFFERS OVERALL MARKET SIZE

2.1 Global Biopharmaceutical Buffers Market Size: 2021 VS 2028
2.2 Global Biopharmaceutical Buffers Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Biopharmaceutical Buffers Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Biopharmaceutical Buffers Players in Global Market
3.2 Top Global Biopharmaceutical Buffers Companies Ranked by Revenue
3.3 Global Biopharmaceutical Buffers Revenue by Companies
3.4 Global Biopharmaceutical Buffers Sales by Companies
3.5 Global Biopharmaceutical Buffers Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Biopharmaceutical Buffers Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Biopharmaceutical Buffers Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biopharmaceutical Buffers Players in Global Market
  3.8.1 List of Global Tier 1 Biopharmaceutical Buffers Companies
  3.8.2 List of Global Tier 2 and Tier 3 Biopharmaceutical Buffers Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Biopharmaceutical Buffers Market Size Markets, 2021 & 2028
  4.1.2 Sterile Buffer
  4.1.3 Non-sterile Buffer
4.2 By Type - Global Biopharmaceutical Buffers Revenue & Forecasts
  4.2.1 By Type - Global Biopharmaceutical Buffers Revenue, 2017-2022
  4.2.2 By Type - Global Biopharmaceutical Buffers Revenue, 2023-2028
  4.2.3 By Type - Global Biopharmaceutical Buffers Revenue Market Share, 2017-2028
4.3 By Type - Global Biopharmaceutical Buffers Sales & Forecasts
  4.3.1 By Type - Global Biopharmaceutical Buffers Sales, 2017-2022
  4.3.2 By Type - Global Biopharmaceutical Buffers Sales, 2023-2028
  4.3.3 By Type - Global Biopharmaceutical Buffers Sales Market Share, 2017-2028
4.4 By Type - Global Biopharmaceutical Buffers Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Biopharmaceutical Buffers Market Size, 2021 & 2028
  5.1.2 Recombinant Proteins
  5.1.3 Monoclonal Antibodies
  5.1.4 Antibiotics
  5.1.5 Probiotics
  5.1.6 Other
5.2 By Application - Global Biopharmaceutical Buffers Revenue & Forecasts
  5.2.1 By Application - Global Biopharmaceutical Buffers Revenue, 2017-2022
  5.2.2 By Application - Global Biopharmaceutical Buffers Revenue, 2023-2028
  5.2.3 By Application - Global Biopharmaceutical Buffers Revenue Market Share, 2017-2028
5.3 By Application - Global Biopharmaceutical Buffers Sales & Forecasts
  5.3.1 By Application - Global Biopharmaceutical Buffers Sales, 2017-2022
  5.3.2 By Application - Global Biopharmaceutical Buffers Sales, 2023-2028
  5.3.3 By Application - Global Biopharmaceutical Buffers Sales Market Share, 2017-2028
5.4 By Application - Global Biopharmaceutical Buffers Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Biopharmaceutical Buffers Market Size, 2021 & 2028
6.2 By Region - Global Biopharmaceutical Buffers Revenue & Forecasts
  6.2.1 By Region - Global Biopharmaceutical Buffers Revenue, 2017-2022
  6.2.2 By Region - Global Biopharmaceutical Buffers Revenue, 2023-2028
  6.2.3 By Region - Global Biopharmaceutical Buffers Revenue Market Share, 2017-2028
6.3 By Region - Global Biopharmaceutical Buffers Sales & Forecasts
  6.3.1 By Region - Global Biopharmaceutical Buffers Sales, 2017-2022
  6.3.2 By Region - Global Biopharmaceutical Buffers Sales, 2023-2028
  6.3.3 By Region - Global Biopharmaceutical Buffers Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Biopharmaceutical Buffers Revenue, 2017-2028
  6.4.2 By Country - North America Biopharmaceutical Buffers Sales, 2017-2028
  6.4.3 US Biopharmaceutical Buffers Market Size, 2017-2028
  6.4.4 Canada Biopharmaceutical Buffers Market Size, 2017-2028
  6.4.5 Mexico Biopharmaceutical Buffers Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Biopharmaceutical Buffers Revenue, 2017-2028
  6.5.2 By Country - Europe Biopharmaceutical Buffers Sales, 2017-2028
  6.5.3 Germany Biopharmaceutical Buffers Market Size, 2017-2028
  6.5.4 France Biopharmaceutical Buffers Market Size, 2017-2028
  6.5.5 U.K. Biopharmaceutical Buffers Market Size, 2017-2028
  6.5.6 Italy Biopharmaceutical Buffers Market Size, 2017-2028
  6.5.7 Russia Biopharmaceutical Buffers Market Size, 2017-2028
  6.5.8 Nordic Countries Biopharmaceutical Buffers Market Size, 2017-2028
  6.5.9 Benelux Biopharmaceutical Buffers Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Biopharmaceutical Buffers Revenue, 2017-2028
  6.6.2 By Region - Asia Biopharmaceutical Buffers Sales, 2017-2028
  6.6.3 China Biopharmaceutical Buffers Market Size, 2017-2028
  6.6.4 Japan Biopharmaceutical Buffers Market Size, 2017-2028
  6.6.5 South Korea Biopharmaceutical Buffers Market Size, 2017-2028
  6.6.6 Southeast Asia Biopharmaceutical Buffers Market Size, 2017-2028
  6.6.7 India Biopharmaceutical Buffers Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Biopharmaceutical Buffers Revenue, 2017-2028
  6.7.2 By Country - South America Biopharmaceutical Buffers Sales, 2017-2028
  6.7.3 Brazil Biopharmaceutical Buffers Market Size, 2017-2028
  6.7.4 Argentina Biopharmaceutical Buffers Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Biopharmaceutical Buffers Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Biopharmaceutical Buffers Sales, 2017-2028
  6.8.3 Turkey Biopharmaceutical Buffers Market Size, 2017-2028
  6.8.4 Israel Biopharmaceutical Buffers Market Size, 2017-2028
  6.8.5 Saudi Arabia Biopharmaceutical Buffers Market Size, 2017-2028
  6.8.6 UAE Biopharmaceutical Buffers Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 GE Healthcare
  7.1.1 GE Healthcare Corporate Summary
  7.1.2 GE Healthcare Business Overview
  7.1.3 GE Healthcare Biopharmaceutical Buffers Major Product Offerings
  7.1.4 GE Healthcare Biopharmaceutical Buffers Sales and Revenue in Global (2017-2022)
  7.1.5 GE Healthcare Key News
7.2 Thermo Fisher Scientific
  7.2.1 Thermo Fisher Scientific Corporate Summary
  7.2.2 Thermo Fisher Scientific Business Overview
  7.2.3 Thermo Fisher Scientific Biopharmaceutical Buffers Major Product Offerings
  7.2.4 Thermo Fisher Scientific Biopharmaceutical Buffers Sales and Revenue in Global (2017-2022)
  7.2.5 Thermo Fisher Scientific Key News
7.3 Danaher Corporation
  7.3.1 Danaher Corporation Corporate Summary
  7.3.2 Danaher Corporation Business Overview
  7.3.3 Danaher Corporation Biopharmaceutical Buffers Major Product Offerings
  7.3.4 Danaher Corporation Biopharmaceutical Buffers Sales and Revenue in Global (2017-2022)
  7.3.5 Danaher Corporation Key News
7.4 Sartorius StedimBiotech
  7.4.1 Sartorius StedimBiotech Corporate Summary
  7.4.2 Sartorius StedimBiotech Business Overview
  7.4.3 Sartorius StedimBiotech Biopharmaceutical Buffers Major Product Offerings
  7.4.4 Sartorius StedimBiotech Biopharmaceutical Buffers Sales and Revenue in Global (2017-2022)
  7.4.5 Sartorius StedimBiotech Key News
7.5 Merck
  7.5.1 Merck Corporate Summary
  7.5.2 Merck Business Overview
  7.5.3 Merck Biopharmaceutical Buffers Major Product Offerings
  7.5.4 Merck Biopharmaceutical Buffers Sales and Revenue in Global (2017-2022)
  7.5.5 Merck Key News
7.6 Eppendorf
  7.6.1 Eppendorf Corporate Summary
  7.6.2 Eppendorf Business Overview
  7.6.3 Eppendorf Biopharmaceutical Buffers Major Product Offerings
  7.6.4 Eppendorf Biopharmaceutical Buffers Sales and Revenue in Global (2017-2022)
  7.6.5 Eppendorf Key News
7.7 Roche
  7.7.1 Roche Corporate Summary
  7.7.2 Roche Business Overview
  7.7.3 Roche Biopharmaceutical Buffers Major Product Offerings
  7.7.4 Roche Biopharmaceutical Buffers Sales and Revenue in Global (2017-2022)
  7.7.5 Roche Key News
7.8 Nova Biomedicals
  7.8.1 Nova Biomedicals Corporate Summary
  7.8.2 Nova Biomedicals Business Overview
  7.8.3 Nova Biomedicals Biopharmaceutical Buffers Major Product Offerings
  7.8.4 Nova Biomedicals Biopharmaceutical Buffers Sales and Revenue in Global (2017-2022)
  7.8.5 Nova Biomedicals Key News
7.9 Lonza
  7.9.1 Lonza Corporate Summary
  7.9.2 Lonza Business Overview
  7.9.3 Lonza Biopharmaceutical Buffers Major Product Offerings
  7.9.4 Lonza Biopharmaceutical Buffers Sales and Revenue in Global (2017-2022)
  7.9.5 Lonza Key News
7.10 Becton, and Dickinson and Company
  7.10.1 Becton, and Dickinson and Company Corporate Summary
  7.10.2 Becton, and Dickinson and Company Business Overview
  7.10.3 Becton, and Dickinson and Company Biopharmaceutical Buffers Major Product Offerings
  7.10.4 Becton, and Dickinson and Company Biopharmaceutical Buffers Sales and Revenue in Global (2017-2022)
  7.10.5 Becton, and Dickinson and Company Key News
7.11 GEA
  7.11.1 GEA Corporate Summary
  7.11.2 GEA Biopharmaceutical Buffers Business Overview
  7.11.3 GEA Biopharmaceutical Buffers Major Product Offerings
  7.11.4 GEA Biopharmaceutical Buffers Sales and Revenue in Global (2017-2022)
  7.11.5 GEA Key News

8 GLOBAL BIOPHARMACEUTICAL BUFFERS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Biopharmaceutical Buffers Production Capacity, 2017-2028
8.2 Biopharmaceutical Buffers Production Capacity of Key Manufacturers in Global Market
8.3 Global Biopharmaceutical Buffers Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 BIOPHARMACEUTICAL BUFFERS SUPPLY CHAIN ANALYSIS

10.1 Biopharmaceutical Buffers Industry Value Chain
10.2 Biopharmaceutical Buffers Upstream Market
10.3 Biopharmaceutical Buffers Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Biopharmaceutical Buffers Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

LIST OF TABLES

Table 1. Key Players of Biopharmaceutical Buffers in Global Market
Table 2. Top Biopharmaceutical Buffers Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Biopharmaceutical Buffers Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Biopharmaceutical Buffers Revenue Share by Companies, 2017-2022
Table 5. Global Biopharmaceutical Buffers Sales by Companies, (K MT), 2017-2022
Table 6. Global Biopharmaceutical Buffers Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Biopharmaceutical Buffers Price (2017-2022) & (USD/MT)
Table 8. Global Manufacturers Biopharmaceutical Buffers Product Type
Table 9. List of Global Tier 1 Biopharmaceutical Buffers Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biopharmaceutical Buffers Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Biopharmaceutical Buffers Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Biopharmaceutical Buffers Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Biopharmaceutical Buffers Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Biopharmaceutical Buffers Sales (K MT), 2017-2022
Table 15. By Type - Global Biopharmaceutical Buffers Sales (K MT), 2023-2028
Table 16. By Application – Global Biopharmaceutical Buffers Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Biopharmaceutical Buffers Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Biopharmaceutical Buffers Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Biopharmaceutical Buffers Sales (K MT), 2017-2022
Table 20. By Application - Global Biopharmaceutical Buffers Sales (K MT), 2023-2028
Table 21. By Region – Global Biopharmaceutical Buffers Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Biopharmaceutical Buffers Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Biopharmaceutical Buffers Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Biopharmaceutical Buffers Sales (K MT), 2017-2022
Table 25. By Region - Global Biopharmaceutical Buffers Sales (K MT), 2023-2028
Table 26. By Country - North America Biopharmaceutical Buffers Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Biopharmaceutical Buffers Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Biopharmaceutical Buffers Sales, (K MT), 2017-2022
Table 29. By Country - North America Biopharmaceutical Buffers Sales, (K MT), 2023-2028
Table 30. By Country - Europe Biopharmaceutical Buffers Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Biopharmaceutical Buffers Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Biopharmaceutical Buffers Sales, (K MT), 2017-2022
Table 33. By Country - Europe Biopharmaceutical Buffers Sales, (K MT), 2023-2028
Table 34. By Region - Asia Biopharmaceutical Buffers Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Biopharmaceutical Buffers Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Biopharmaceutical Buffers Sales, (K MT), 2017-2022
Table 37. By Region - Asia Biopharmaceutical Buffers Sales, (K MT), 2023-2028
Table 38. By Country - South America Biopharmaceutical Buffers Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Biopharmaceutical Buffers Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Biopharmaceutical Buffers Sales, (K MT), 2017-2022
Table 41. By Country - South America Biopharmaceutical Buffers Sales, (K MT), 2023-2028
Table 42. By Country - Middle East & Africa Biopharmaceutical Buffers Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Biopharmaceutical Buffers Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Biopharmaceutical Buffers Sales, (K MT), 2017-2022
Table 45. By Country - Middle East & Africa Biopharmaceutical Buffers Sales, (K MT), 2023-2028
Table 46. GE Healthcare Corporate Summary
Table 47. GE Healthcare Biopharmaceutical Buffers Product Offerings
Table 48. GE Healthcare Biopharmaceutical Buffers Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 49. Thermo Fisher Scientific Corporate Summary
Table 50. Thermo Fisher Scientific Biopharmaceutical Buffers Product Offerings
Table 51. Thermo Fisher Scientific Biopharmaceutical Buffers Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 52. Danaher Corporation Corporate Summary
Table 53. Danaher Corporation Biopharmaceutical Buffers Product Offerings
Table 54. Danaher Corporation Biopharmaceutical Buffers Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 55. Sartorius StedimBiotech Corporate Summary
Table 56. Sartorius StedimBiotech Biopharmaceutical Buffers Product Offerings
Table 57. Sartorius StedimBiotech Biopharmaceutical Buffers Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 58. Merck Corporate Summary
Table 59. Merck Biopharmaceutical Buffers Product Offerings
Table 60. Merck Biopharmaceutical Buffers Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 61. Eppendorf Corporate Summary
Table 62. Eppendorf Biopharmaceutical Buffers Product Offerings
Table 63. Eppendorf Biopharmaceutical Buffers Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 64. Roche Corporate Summary
Table 65. Roche Biopharmaceutical Buffers Product Offerings
Table 66. Roche Biopharmaceutical Buffers Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 67. Nova Biomedicals Corporate Summary
Table 68. Nova Biomedicals Biopharmaceutical Buffers Product Offerings
Table 69. Nova Biomedicals Biopharmaceutical Buffers Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 70. Lonza Corporate Summary
Table 71. Lonza Biopharmaceutical Buffers Product Offerings
Table 72. Lonza Biopharmaceutical Buffers Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 73. Becton, and Dickinson and Company Corporate Summary
Table 74. Becton, and Dickinson and Company Biopharmaceutical Buffers Product Offerings
Table 75. Becton, and Dickinson and Company Biopharmaceutical Buffers Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 76. GEA Corporate Summary
Table 77. GEA Biopharmaceutical Buffers Product Offerings
Table 78. GEA Biopharmaceutical Buffers Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 79. Biopharmaceutical Buffers Production Capacity (K MT) of Key Manufacturers in Global Market, 2020-2022 (K MT)
Table 80. Global Biopharmaceutical Buffers Capacity Market Share of Key Manufacturers, 2020-2022
Table 81. Global Biopharmaceutical Buffers Production by Region, 2017-2022 (K MT)
Table 82. Global Biopharmaceutical Buffers Production by Region, 2023-2028 (K MT)
Table 83. Biopharmaceutical Buffers Market Opportunities & Trends in Global Market
Table 84. Biopharmaceutical Buffers Market Drivers in Global Market
Table 85. Biopharmaceutical Buffers Market Restraints in Global Market
Table 86. Biopharmaceutical Buffers Raw Materials
Table 87. Biopharmaceutical Buffers Raw Materials Suppliers in Global Market
Table 88. Typical Biopharmaceutical Buffers Downstream
Table 89. Biopharmaceutical Buffers Downstream Clients in Global Market
Table 90. Biopharmaceutical Buffers Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Biopharmaceutical Buffers Segment by Type
Figure 2. Biopharmaceutical Buffers Segment by Application
Figure 3. Global Biopharmaceutical Buffers Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Biopharmaceutical Buffers Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Biopharmaceutical Buffers Revenue, 2017-2028 (US$, Mn)
Figure 7. Biopharmaceutical Buffers Sales in Global Market: 2017-2028 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Biopharmaceutical Buffers Revenue in 2021
Figure 9. By Type - Global Biopharmaceutical Buffers Sales Market Share, 2017-2028
Figure 10. By Type - Global Biopharmaceutical Buffers Revenue Market Share, 2017-2028
Figure 11. By Type - Global Biopharmaceutical Buffers Price (USD/MT), 2017-2028
Figure 12. By Application - Global Biopharmaceutical Buffers Sales Market Share, 2017-2028
Figure 13. By Application - Global Biopharmaceutical Buffers Revenue Market Share, 2017-2028
Figure 14. By Application - Global Biopharmaceutical Buffers Price (USD/MT), 2017-2028
Figure 15. By Region - Global Biopharmaceutical Buffers Sales Market Share, 2017-2028
Figure 16. By Region - Global Biopharmaceutical Buffers Revenue Market Share, 2017-2028
Figure 17. By Country - North America Biopharmaceutical Buffers Revenue Market Share, 2017-2028
Figure 18. By Country - North America Biopharmaceutical Buffers Sales Market Share, 2017-2028
Figure 19. US Biopharmaceutical Buffers Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Biopharmaceutical Buffers Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Biopharmaceutical Buffers Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Biopharmaceutical Buffers Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Biopharmaceutical Buffers Sales Market Share, 2017-2028
Figure 24. Germany Biopharmaceutical Buffers Revenue, (US$, Mn), 2017-2028
Figure 25. France Biopharmaceutical Buffers Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Biopharmaceutical Buffers Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Biopharmaceutical Buffers Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Biopharmaceutical Buffers Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Biopharmaceutical Buffers Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Biopharmaceutical Buffers Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Biopharmaceutical Buffers Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Biopharmaceutical Buffers Sales Market Share, 2017-2028
Figure 33. China Biopharmaceutical Buffers Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Biopharmaceutical Buffers Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Biopharmaceutical Buffers Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Biopharmaceutical Buffers Revenue, (US$, Mn), 2017-2028
Figure 37. India Biopharmaceutical Buffers Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Biopharmaceutical Buffers Revenue Market Share, 2017-2028
Figure 39. By Country - South America Biopharmaceutical Buffers Sales Market Share, 2017-2028
Figure 40. Brazil Biopharmaceutical Buffers Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Biopharmaceutical Buffers Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Biopharmaceutical Buffers Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Biopharmaceutical Buffers Sales Market Share, 2017-2028
Figure 44. Turkey Biopharmaceutical Buffers Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Biopharmaceutical Buffers Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Biopharmaceutical Buffers Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Biopharmaceutical Buffers Revenue, (US$, Mn), 2017-2028
Figure 48. Global Biopharmaceutical Buffers Production Capacity (K MT), 2017-2028
Figure 49. The Percentage of Production Biopharmaceutical Buffers by Region, 2021 VS 2028
Figure 50. Biopharmaceutical Buffers Industry Value Chain
Figure 51. Marketing Channels


More Publications